您的位置: 首页 > 2018年7月 第49卷 第4期 > 文字全文
2023年7月 第38卷 第7期11
目录

年龄与性别对鼻咽癌患者自我病情延误的影响

Age and gender affect self-delay of nasopharyngeal carcinoma patients

来源期刊: 广州医药 | 88-90 发布时间:2021-11-29 收稿时间:2025/11/13 17:20:51 阅读量:25
作者:
关键词:
鼻咽癌延误年龄性别
DOI:
10.3969/j.issn.1000-8535.2018.04.024
收稿时间:
2018-03-26 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 以临床病例为研究对象,探讨年龄与性别对鼻咽癌自我病情延误的影响,寻找鼻咽癌科普宣教的重点靶标人群。方法 收集2015年4月—2015年12月广州医科大学附属肿瘤医院放疗科鼻咽癌病区收治的经活检病理确诊初治鼻咽癌患者62例(年龄28~77岁,中位年龄49岁),记录患者主诉症征出现至病理确诊鼻咽癌其相关症状的持续时间,采用t检验和Pearson相关分析探讨性别及年龄对鼻咽癌确诊前相关症征持续时间的影响。结果 62例患者确诊前均自我发现鼻咽癌相关症征,其中43例(69.4%)发现鼻咽原发灶相关症状,35例(56.5%)发现颈部淋巴肿大症状。Pearson相关分析显示,鼻咽癌确诊前颈部淋巴结肿大持续时间与年龄呈正相关(P<0.05);t检验结果显示,男性患者鼻咽癌确诊前症状持续时间大于女性患者(P<0.05)。结论 年龄较大和男性人群鼻咽癌自我病情延误较为严重,应该作为包括临床症状在内的鼻咽癌科普宣教的重点人群。
1、 WEI K R,ZHENG R S,ZHANG S W,et al. Nasopharyngeal carcinoma incidence and mortality in China in 2010[J]. Chin J Cancer,2014,33(8):381-387. WEI K R,ZHENG R S,ZHANG S W,et al. Nasopharyngeal carcinoma incidence and mortality in China in 2010[J]. Chin J Cancer,2014,33(8):381-387.
2、 LIANG X,YANG J,GAO T,et al. Nasopharynx cancer epidemiology in China[J]. Chin Cancer, 2016,25(11):835-840. LIANG X,YANG J,GAO T,et al. Nasopharynx cancer epidemiology in China[J]. Chin Cancer, 2016,25(11):835-840.
3、 CHEN W,ZHENG R,BAADE P D,et al. Cancer statistics in China,2015[J]. CA Cancer J Clin,2016,66(2):115-132. CHEN W,ZHENG R,BAADE P D,et al. Cancer statistics in China,2015[J]. CA Cancer J Clin,2016,66(2):115-132.
4、 CHANG E T,ADAMI H O. The enigmatic epidemiology of nasopharyngeal carcinoma[J]. Cancer Epidemiol Biomarkers Prev,2006,15(10):1765-1777. CHANG E T,ADAMI H O. The enigmatic epidemiology of nasopharyngeal carcinoma[J]. Cancer Epidemiol Biomarkers Prev,2006,15(10):1765-1777.
5、 包婺安,陈晓钟,胡福军,等.浙江省鼻咽癌诊治现状及挑战[J]. 中国肿瘤,2013,22(10):771-776. 包婺安,陈晓钟,胡福军,等.浙江省鼻咽癌诊治现状及挑战[J]. 中国肿瘤,2013,22(10):771-776.
6、 ZHENG R H, KONG C Q, TIAN Y H, et al. The analysis of the present statu of early diagnosis and misdiagnosis of nasopharyngeal carcinoma inGuangdong province[J]. Cancer Res Prev Treat 2016,32(12): 1952-1955. ZHENG R H, KONG C Q, TIAN Y H, et al. The analysis of the present statu of early diagnosis and misdiagnosis of nasopharyngeal carcinoma inGuangdong province[J]. Cancer Res Prev Treat 2016,32(12): 1952-1955.
7、 李家祥,程宇文,周冠群.PF诱导化疗联合调强放疗及二维放疗对鼻咽癌近远期疗效影响的回顾性分析[J]. 广州医药,2016,47(3):31-33. 李家祥,程宇文,周冠群.PF诱导化疗联合调强放疗及二维放疗对鼻咽癌近远期疗效影响的回顾性分析[J]. 广州医药,2016,47(3):31-33.
8、 林仙煌,关秀碧,吴庆彩,等.鼻咽癌同期放化疗期间体重变化相关研究[J]. 现代医院,2015,(7):41-42. 林仙煌,关秀碧,吴庆彩,等.鼻咽癌同期放化疗期间体重变化相关研究[J]. 现代医院,2015,(7):41-42.
9、 赫捷, 陈万青. 2012 中国肿瘤登记年报[M]. 北京:军事医学科学出版社,2013:87-90. 赫捷, 陈万青. 2012 中国肿瘤登记年报[M]. 北京:军事医学科学出版社,2013:87-90.
10、 ZENG H,ZHENG R,GUO Y,et al. Cancer survival in China,2003 -2005:a population-based study[J]. Int J Cancer,2015,136(8):1921-1930. ZENG H,ZHENG R,GUO Y,et al. Cancer survival in China,2003 -2005:a population-based study[J]. Int J Cancer,2015,136(8):1921-1930.
11、 HUANG T R,ZHANG S W,CHEN W Q,et al. Trends in nasopharyngeal carcinoma mortality in China,1973-2005[J]. Asian Pac J Cancer Prev,2012,13(6):2495-2502. HUANG T R,ZHANG S W,CHEN W Q,et al. Trends in nasopharyngeal carcinoma mortality in China,1973-2005[J]. Asian Pac J Cancer Prev,2012,13(6):2495-2502.
12、 XU Z J,ZHENG R S,ZHANG S W,et al. Nasopharyngeal carcinoma incidence and mortality in China in 2009[J]. Chin J Cancer,2013,32(8):453-460. XU Z J,ZHENG R S,ZHANG S W,et al. Nasopharyngeal carcinoma incidence and mortality in China in 2009[J]. Chin J Cancer,2013,32(8):453-460.
13、 CHEN W Q, ZHENG R S, ZHANG S W,et al. Report of cancer incidence and mortality in China,2010[J]. Ann Transl Med,2014,2(7):61. CHEN W Q, ZHENG R S, ZHANG S W,et al. Report of cancer incidence and mortality in China,2010[J]. Ann Transl Med,2014,2(7):61.
14、 CHEN W Q,ZHENG R S,ZENG H M,et al. Annual report on status of cancer in China,2011[J]. Chin J Cancer Res,2015,27(1):48-58. CHEN W Q,ZHENG R S,ZENG H M,et al. Annual report on status of cancer in China,2011[J]. Chin J Cancer Res,2015,27(1):48-58.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录